中国药师
中國藥師
중국약사
CHINA PHARMACIST
2014年
12期
2159-2161
,共3页
氯氮平%有关物质%高效液相色谱法
氯氮平%有關物質%高效液相色譜法
록담평%유관물질%고효액상색보법
Clozapine%Related substances%HPLC
目的::对氯氮平及其制剂的有关物质进行分析研究。方法:采用《中国药典》及《美国药典》( USP)的方法进行对比分析。结果:国产原料与进口原料杂质谱基本一致,制剂杂质谱与原料杂质谱基本一致,USP所用方法对杂质的分离优于《中国药典》所用方法。结论:《中国药典》现行法定检验标准检验有待研究提高。
目的::對氯氮平及其製劑的有關物質進行分析研究。方法:採用《中國藥典》及《美國藥典》( USP)的方法進行對比分析。結果:國產原料與進口原料雜質譜基本一緻,製劑雜質譜與原料雜質譜基本一緻,USP所用方法對雜質的分離優于《中國藥典》所用方法。結論:《中國藥典》現行法定檢驗標準檢驗有待研究提高。
목적::대록담평급기제제적유관물질진행분석연구。방법:채용《중국약전》급《미국약전》( USP)적방법진행대비분석。결과:국산원료여진구원료잡질보기본일치,제제잡질보여원료잡질보기본일치,USP소용방법대잡질적분리우우《중국약전》소용방법。결론:《중국약전》현행법정검험표준검험유대연구제고。
Objective: To study the related substances in clozapine and its preparations. Methods:Comparative analysis was adopted according to the method respectively described in Chinese pharmacopoeia and United States pharmacopoeia. Results:The impurity profile of clozapine from domestic and abroad was basically the same, and that of clozapine and its preparations was also basically the same. The method in United States pharmacopoeia was better than that in Chinese pharmacopoeia in terms of in terms of separation of the impurities. Conclusion: The current legal inspection standard for the related substances in clozapine described in Chinese pharmacopoeia should be improved.